INTRODUCTION
============

Voltage-gated calcium channels (Ca~V~s) serve as a major source of calcium influx in excitable cells ([@bib38]). Calcium ions have a unique biological role in that they act as both charge carriers and as chemical messengers ([@bib17]). Thus, Ca~V~ activity provides a vital link between membrane potential charges and stimulation of calcium-driven intracellular signaling cascades that directly affect processes such as excitation--contraction coupling, neurotransmitter release, and gene regulation ([@bib11]). High voltage--activated channels consist of four essential components ([@bib81]): a pore-forming Ca~V~α~1~ subunit from either Ca~V~1 or Ca~V~2 isoforms ([@bib11]), a cytoplasmic Ca~V~β subunit ([@bib23]), the transmembrane Ca~V~α~2~δ subunit ([@bib19]), and calmodulin (CaM) ([@bib57]). Two intracellular components of the complex, Ca~V~β and CaM, play central roles in channel modulation processes that affect calcium influx. In particular, both affect channel inactivation, a generalized term for phenomena that limit channel conduction and calcium influx under conditions in which the channel would otherwise remain open.

The two principal Ca~V~ inactivation processes are voltage-dependent inactivation (VDI) ([@bib73]; [@bib13]) and calcium-dependent inactivation (CDI) ([@bib13]; [@bib34]). The molecular origins of VDI are complex and have remained imperfectly understood ([@bib73]). The predominant contributions appear to arise from the Ca~V~β subunit ([@bib53]; [@bib71]; [@bib20]), Ca~V~α~1~ transmembrane segment IS6 ([@bib86]; [@bib60]), and the Ca~V~α~1~ intracellular I-II loop ([@bib37]; [@bib67]; [@bib72]; [@bib8]; [@bib29]), although mutations in other transmembrane segments ([@bib72]; [@bib5]; [@bib65]; [@bib60], [@bib59]), the cytoplasmic N-terminal domain ([@bib44]; [@bib41]), the C-terminal EF-hand region ([@bib6]), and the CaM-interaction domain ([@bib47]; [@bib43]; [@bib4]) have also been shown to affect VDI. The central role of Ca~V~β in VDI is evident from the diverse VDI rates bestowed upon Ca~V~1 and Ca~V~2 Ca~V~α~1~ subunits through association with particular Ca~V~β isoforms. Ca~V~β~2a~ slows VDI considerably ([@bib53]; [@bib71]; [@bib20]), a consequence of the anchoring of its N terminus to the membrane by palmitoylation ([@bib15]; [@bib58]). In contrast, Ca~V~β~1~, Ca~V~β~2b~, and Ca~V~β~3~, which lack the palmitoylation site found in Ca~V~β~2a~, support fast VDI ([@bib53]; [@bib71]; [@bib20]). The discovery that IS6 mutations that drastically reduce Ca~V~1.2 VDI cause a multisystem disorder involving lethal heart arrhythmias, cognitive abnormalities, and immune deficiencies, known as Timothy syndrome ([@bib70], [@bib69]), provides further evidence for the importance of IS6 in channel gating and a compelling example of the physiological relevance of VDI.

Structural studies have revealed that the high affinity Ca~V~β-binding site present on the I-II loop, the α-interaction domain (AID), forms an α-helix that interacts extensively with a deep pocket on Ca~V~β, the α-binding pocket ([@bib14]; [@bib54]; [@bib79]). Although absent from the crystal structures, the 22 residues that bridge the C-terminal cytoplasmic end of the pore-lining IS6 helix and N-terminal end of the AID α-helix, the IS6-AID linker, have been noted to have a high α-helix propensity ([@bib54]; [@bib79]). This observation raises the possibility that the IS6-AID linker forms a continuous helix between IS6 and AID that acts as a rigid rod through which Ca~V~β affects channel gating ([@bib54]; [@bib79]). Partial support for this idea comes from functional studies of chimeras between the low voltage--activated Ca~V~3.1, a Ca~V~α~1~ subunit that lacks Ca~V~β modulation, and the Ca~V~2.2 I-II loop ([@bib2]). Fusion of the Ca~V~2.2 I-II loop to the end of Ca~V~3.1 IS6 endowed the chimeric channel with Ca~V~β-dependent modulation that could be eliminated by hexaglycine mutations in the IS6-AID linker. Nevertheless, a detailed investigation of the role of the IS6-AID linker in the context of channels that are natively modulated by Ca~V~βs has not been reported.

Ca^2+^/CaM binding to the IQ domain, which is located in the Ca~V~α~1~ subunit cytoplasmic C-terminal tail, drives CDI ([@bib89]; [@bib25]; [@bib34]) as well as calcium-dependent facilitation (CDF), an increase in peak current upon repetitive stimuli ([@bib89]; [@bib21]; [@bib78]; [@bib46]). The IQ domain is ∼200 residues C terminal to the last transmembrane segment IVS6. Although crystallographic studies have revealed the nature of the Ca^2+^/CaM-IQ domain interaction ([@bib26]; [@bib78]), it is not known how the binding of Ca^2+^/CaM to a site seemingly distant from the transmembrane pore affects gating.

Even though many models have been proposed, it is unclear how VDI and CDI proceed and whether they use separate ([@bib4]) or common mechanisms ([@bib12]; [@bib43]). Here, we show that both the Ca~V~β subunit and the integrity of the IS6-AID linker affect VDI, CDI, and CDF profoundly, and that an intact IS6-AID linker is required for both the Ca~V~β and Ca^2+^/CaM-IQ domain cytoplasmic elements to modulate the activity of the transmembrane pore. These results provide strong evidence for a model in which VDI, CDI, and CDF act through mediation of the protein--protein complex formed by Ca~V~β and the IS6-AID linker.

MATERIALS AND METHODS
=====================

Molecular Biology
-----------------

Constructs for electrophysiology consisted of human Ca~V~1.2 (α~1~C77; GenBank accession no. [CAA84346](CAA84346)) in pcDNA3.1 (Invitrogen), rabbit Ca~V~2.1 (GenBank accession no. [X57477](X57477)) in pGEMHE, rabbit Ca~V~β~1~ (GenBank accession no. [M25514](M25514)) in pSP65, rat Ca~V~β~2a~ (GenBank accession no. [NP_446303](NP_446303)) in pGEMHE, rabbit Ca~V~β~2b~ (GenBank accession no. [X64298](X64298)) in pSPORT1 (Promega), and rabbit Ca~V~α~2~δ-1 (GenBank accession no. [NM_001082276](NM_001082276)) in pcDNA3.1. ssCa~V~β~2a~ is a double mutant (C3S and C4S) of rat Ca~V~β~2a~. To facilitate mutagenesis of the I-II loop region of Ca~V~1.2, a silent HpaI site was added at nucleotide positions 1,114--1,119 to create an excisable fragment framed by the HpaI site and a naturally occurring PpuMI site at nucleotide positions 2,759--2,765. This fragment was excised and ligated into a pGEMHE backbone to serve as a template for mutagenesis. Similarly, for Ca~V~2.1 I-II loop mutagenesis, a ClaI site from the vector N terminal to the Ca~V~2.1 coding region and the naturally occurring XhoI site at nucleotide positions 1,395--1,400 framed a fragment that was excised and ligated into a pGEMHE backbone to serve as a cloning cassette. Mutations were introduced in the cloning cassette using QuikChange (Agilent Technologies), and mutated fragments were religated into their parent vector. Each mutant was sequenced in the final vector across either the entire channel coding sequence or the mutated fragment and points of reinsertion only, as appropriate.

Electrophysiological Recordings and Data Analysis
-------------------------------------------------

After overnight linearization of the vector (pCDNA3 with XhoI, pGEMHE with NheI, pSPORT1 with NotI, and pSP65 with XbaI), capped mRNA was synthesized with the T7 or SP6 Messenger kit (Applied Biosystems), as appropriate. 50 nl of equimolar Ca~V~α~1~, Ca~V~β, and Ca~V~α~2~δ-1 mRNA at final concentrations of 33--100 nM were injected into de-folliculated *Xenopus* oocytes prepared as described previously ([@bib78]). Two-electrode voltage clamp experiments were performed 2--5 d after injection using a GeneClamp 500B (MDS Analytical Technologies) amplifier controlled by a 1,200-MHz processor computer (Celeron; Gateway) running CLAMPEX 8.2.0.244 and digitized at 1 kHz with a Digidata 1332A (MDS Analytical Technologies). Immediately before recording, oocytes were injected with 50 nl of 100 mM BAPTA to minimize Ca^2+^-activated Cl^−^ current. Recording solutions contained either 40 mM Ba(OH)~2~ or 40 mM Ca(NO~3~)~2~, 50 mM NaOH, 1 mM KOH, and 10 mM HEPES. Both solutions were adjusted to pH 7.4 using HNO~3~. Electrodes were filled with 3M KCl and had resistances of 0.3--2.0 MΩ. Leak currents were subtracted using a P/4 protocol. Currents were analyzed with Clampfit 8.2 (MDS Analytical Technologies). During recordings, oocytes were superfused using a Valvelink 16 controller (Automate Scientific). All results are from at least two independent oocyte batches. G~max~, V~0.5~, and K~a~ were calculated by recording a series of 450-ms pulses from −50 to +70 mV from a resting potential of −90 mV and fitting them to the equation: I = G~max~ \* (V~m~ − V~rev~)/(1 + exp (V~0.5~ − V~m~)/K~a~), where I is the measured peak current at each V~m~, G~max~ is the maximal conductance, V~m~ is the test potential, V~rev~ is the reversal potential, V~0.5~ is the midpoint of activation, and K~a~ is the slope factor ([@bib41]). The t~i300~ and t~i2400~ values were calculated from normalized currents at +20 mV and represent the percentage inactivation after 300 and 2,400 ms, respectively. Ca~V~1.2 currents recorded with calcium as charge carrier show inactivation resulting from two inactivation processes, VDI and CDI. netCDI was determined by dividing the normalized calcium current by the normalized barium current ([@bib4]). Inactivation τ values were calculated at a test potential of +20 mV using the formula I = A~1~ exp (−t/τ~1~) + A~2~ exp (−t/τ~2~) + C, where I is the recorded current, A is the amplitude of the current component, and C is the residual current at steady state. Isochronal inactivation data were obtained using a protocol modified from [@bib8] in which a +20-mV control pulse was followed by a 2-s prepulse to variable potentials and a test pulse to +20 mV. Inactivation in both barium and calcium were measured from the same oocyte and calculated as: Inactivation~(Ba\ or\ Ca)~ = 1 − (i~test~/i~control~) and Inactivation~(netCDI)~ = 1 − (1 − Inactivation ~(Ca)~)/(1 − Inactivation ~(Ba)~). CDF was elicited by a train of 40 50-ms pulses to +20 mV at a frequency of 3 Hz and calculated as the ratio of the peak current from the last pulse divided by the first.

Protein Expression and Purification
-----------------------------------

Wild-type and mutant IS6-AID linker peptides (residues 406--427) expressed as fusion proteins in a pET28 vector, called HMT ([@bib79]), which contains in sequence a hexahistidine tag, maltose-binding protein, and tobacco etch mosaic virus (TEV) protease cleavage site followed by the peptide of interest. HMT fusions were expressed in *Escherichia coli* BL21 (DE3)-pLysS using 2YT media (Teknova) at 37°C and induced at OD~600nm~ = 0.6, with 0.4 mM IPTG for 4 h. Cells were harvested by centrifugation at 6,000 *g* for 20 min at 4°C. Pellets were stored frozen at −20°C until further use. Thawed cells were lysed by sonication in 250 mM KCl and 10 mM KH~2~PO~4~/K~2~HPO~4~, pH 7.3 (Buffer A). After centrifugation at 15,000 *g* at 4°C for 30 min, the soluble fraction was loaded on a nickel-charged Poros20MC column (Applied Biosystems), washed in Buffer A, and eluted using step elution of Buffer A plus 500 mM imidazole, pH 8.0. After overnight cleavage with TEV protease ([@bib42]) at room temperature, the peptides retained an N-terminal tripeptide sequence of Gly-His-Met derived from the TEV cleavage site and a C-terminal tripeptide sequence of Gly-Gly-Trp to allow determination of the peptide concentration. Pure peptide was eluted in Buffer A as the flow-through from an amylose column (New England Biolabs, Inc.) and a Poros20MC column connected in sequence. Aggregated peptide was separated from soluble material using a Superdex75 HR10/30 gel filtration column (GE Healthcare) in Buffer A. The peptide was concentrated using a Vivaspin 15R with a molecular weight cutoff of 2 kD (Vivascience) to 0.05 mM as determined by absorbance ([@bib24]).

Circular Dichroism (CD)
-----------------------

CD spectra were measured in a 2-mm path-length quartz cuvette (Hellma), 50 mM KCl, and 10 mM KH~2~PO~4~/K~2~HPO~4~, pH 7.3, and varying trifluoroethanol (TFE) concentrations using an Aviv Model 215 spectropolarimeter (Aviv Biomedical) equipped with a peltier temperature controller. Wavelength scans from 320 to 190 nm were taken at 4°C. Each point was determined in triplicate from the same sample and subtracted by the average of a triplicate buffer scan. Each sample was checked for purity by HPLC. Molar ellipticity was calculated as follows: θ = 100(Δm)/Cnl, where Δm is the CD signal in millidegrees after buffer subtraction, C is the peptide concentration in millimoles, n is the number of residues in the peptide, and l is the cuvette path length in centimeters. Fraction helix was calculated as F~helix~ = (\[θ\]~obs~ − \[θ\]~coil~)/(\[θ\]~helix~ − \[θ\]~coil~), where (\[θ\]~helix~ and \[θ\]~coil~ signify the mean residue ellipticity that is +640 for random coil and −42,500\*(1--3/n) for complete helix, respectively ([@bib64]).

Online Supplemental Material
----------------------------

Fig. S1 shows the effects of the GGG mutation on Ca~V~1.2 in the absence of Ca~V~β. Fig. S2 shows the influence of Ca~V~α~2~δ on Ca~V~1.2 V~0.5~. Fig. S3 displays the averaged V~0.5~ values of Ca~V~1.2 mutations in barium- and calcium-containing buffers. Fig. S4 shows the effect of Ca~V~β titration on Ca~V~1.2 and Ca~V~1.2 GGG G~max~ values. Fig. S5 compares calcium currents for Ca~V~1.2 6G, Ca~V~1.2 GGG/HotA, and wild-type Ca~V~ 1.2 expressed at similar levels. Table S1 lists the inactivation parameters in calcium-containing buffer for all Ca~V~1.2/Ca~V~β combinations tested. Table S2 presents the current ranges recorded for the channels used in this study. The online supplemental material is available at <http://www.jgp.org/cgi/content/full/jgp.200810143/DC1>.

RESULTS
=======

Glycine Substitution in the IS6-AID Linker Affects VDI
------------------------------------------------------

As noted previously ([@bib54]; [@bib79]), the IS6-AID linker has a high probability to form an α-helical structure ([Fig. 1 A](#fig1){ref-type="fig"}). To disrupt the integrity of this putative helix, we mutated three consecutive residues in the middle of the Ca~V~1.2 IS6-AID linker, residues 415--417, to glycine (denoted as GGG) ([Fig. 1 A](#fig1){ref-type="fig"}). Due to the extremely low helix propensity of glycine ([@bib52]; [@bib9]), the GGG mutation is expected to cause substantial disruption of any helical structure present in the IS6-AID linker, as it should incur an ∼3--kcal mol^−1^ destabilization of the helical conformation. As a control for effects resulting from side chain deletion, we also made a mutant that converts Ca~V~1.2 residues 415--417 into a triple-alanine sequence, denoted as AAA. Based on the high helix--forming propensity of alanine, this substitution should leave the IS6-AID helix intact.

![Glycine substitution in the IS6-AID linker affects VDI. (A) Amino acid sequence of wild-type and mutant IS6-AID linker sequences from Ca~V~1.2 and Ca~V~2.1. SOPMA secondary structure prediction is indicated ([@bib30]). (B) Disruption of the IS6-AID linker accelerates Ca~V~1.2 VDI. Representative normalized I~Ba~ traces at a test potential of +20 mV for the combination of the indicated Ca~V~1.2 subunits and Ca~V~β~2a~. (C) t~i300~ values for data from B. Results of unpaired *t* tests or one-way ANOVA, as appropriate, are indicated as follows: N.S., P \> 0.05, not significant; \*\*\*, P \< 0.001. (D) G-V relationships in barium for the indicated combinations of Ca~V~1.2 subunits and Ca~V~β~2a~. (E) Disruption of the IS6-AID linker accelerates Ca~V~2.1 VDI. Representative normalized I~Ba~ traces of Ca~V~2.1 wild-type and Ca~V~2.1 GGG. Data in all figures are represented as mean ± SD.](JGP_200810143_RGB_Fig1){#fig1}

We used two-electrode voltage clamp recording in *Xenopus* oocytes under conditions in which barium was the charge carrier to examine the consequences of IS6-AID linker mutations in the presence or absence of Ca~V~β~2a~ modulation. When coexpressed with Ca~V~β~2a~, GGG channels inactivated ∼7.6-fold faster than wild-type Ca~V~1.2 channels (τ~1~ = 489 ± 130 ms vs. 3,730 ± 670 ms, respectively) and to a sixfold greater extent at 300 ms after activation (t~i300~ = 13.2 ± 2.5% and 2.2 ± 1.3%, respectively) ([Fig. 1, B and C](#fig1){ref-type="fig"}, and [Table I](#tbl1){ref-type="table"}). In contrast, AAA mutant channels displayed VDI τ and t~i300~ values similar to wild-type Ca~V~1.2 (τ~1~ = 3,290 ± 160 ms; t~i300~ = 1.1 ± 0.6). This result indicates that the functional effects caused by the GGG substitution do not result from the loss of key side chain interactions, but rather from the likely loss of structure in the IS6-AID linker. Further disruption of the IS6-AID linker by a hexa-glycine mutant (Ca~V~1.2 6G) ([Fig. 1 A](#fig1){ref-type="fig"}) resulted in channels having VDI properties that were indistinguishable from Ca~V~1.2 GGG channels (τ~1~ = 485 ± 155 ms; t~i300~ = 13.0 ± 5.6%) ([Fig. 1, B and C](#fig1){ref-type="fig"}, and [Table I](#tbl1){ref-type="table"}). In contrast, the corresponding hexa-alanine mutation (Ca~V~1.2 6A) had properties similar to wild-type channels ([Table I](#tbl1){ref-type="table"}). Thus, additional disruption of the IS6-AID linker had no further functional consequences on VDI beyond what was observed for the GGG mutant.

###### 

Ca~V~1 and Ca~V~2 Inactivation Properties

  Construct                  t~i300~ (%)   t~i2400~ (%)   A~1~ (%)      τ~1~ (ms)     A~2~ (%)     τ~2~ (ms)     *n*
  -------------------------- ------------- -------------- ------------- ------------- ------------ ------------- -----
  VDI                                                                                                            
  Ca~V~1.2, β~2a~            2.2 ± 1.3     10.9 ± 2.6     20.9 ± 3.6    3,730 ± 670   ---          ---           12
  Ca~V~1.2 AAA, β~2a~        1.1 ± 0.6     11.9 ± 5.2     18.5 ± 7.5    3,290 ± 160   ---          ---           5
  Ca~V~1.2 6A, β~2a~         1.8 ± 0.6     16.1 ± 3.1     16.9 ± 1.6    1,880 ± 160   ---          ---           5
  Ca~V~1.2, β~1~             22.3 ± 1.8    62.4 ± 5.2     73.0 ± 5.7    1,150 ± 80    ---          ---           5
  Ca~V~1.2, β~2b~            4.8 ± 1.5     25.2 ± 2.1     44.5 ± 4.9    2,840 ± 630   ---          ---           8
  Ca~V~1.2, ssβ~2a~          7.1 ± 2.9     33.5 ± 7.7     43.3 ± 11.3   2,050 ± 510   ---          ---           6
  Ca~V~1.2                   11.0 ± 3.0    ND             22.7 ± 3.9    455 ± 99      ---          ---           5
  Ca~V~1.2 HotA, β~2a~       8.9 ± 4.1     ND             23.6 ± 7.2    601 ± 211     ---          ---           5
  Ca~V~1.2 GGG, β~2a~        13.2 ± 2.5    ND             30.0 ± 6.6    489 ± 130     ---          ---           11
  Ca~V~1.2 6G, β~2a~         13.0 ± 5.6    ND             34.2 ± 3.4    485 ± 155     ---          ---           6
  Ca~V~1.2 GGG/HotA, β~2a~   8.9 ± 5.6     ND             21.7 ± 7.6    607 ± 277     ---          ---           7
  Ca~V~1.2 GGG               28.1 ± 3.6    ND             41.9 ± 3.8    255 ± 20      ---          ---           7
  Ca~V~1.2 GGG, β~1~         59.6 ± 4.3    ND             79.2 ± 3.7    202 ± 12      ---          ---           6
  Ca~V~1.2 GGG, β~2b~        42.8 ± 3.2    ND             66.0 ± 1.7    264 ± 14      ---          ---           6
  Ca~V~1.2 GGG, ssβ~2a~      47.7 ± 2.8    ND             72.0 ± 5.6    262 ± 14      ---          ---           5
  Ca~V~2.1, β~2a~            6.5 ± 1.2     ND             9.7 ± 1.5     308 ± 80      ---          ---           10
  Ca~V~2.1 GGG, β~2a~        36.9 ± 4.1    ND             59.3 ± 8.6    439 ± 42      9.2 ± 1.9    17.8 ± 2.2    6
  Ca~V~2.1 6G, β~2a~         39.5 ± 9.8    ND             45.3 ± 8.0    326 ± 31      14.5 ± 4.1   13.0 ± 2.3    7
  Ca~V~2.1 AAA, β~2a~        8.2 ± 1.2     ND             11.9 ± 1.6    283 ± 53      ---          ---           7
  Ca~V~2.1 6A, β~2a~         9.6 ± 1.5     ND             14.2 ± 2.2    311 ± 79      ---          ---           7
  Ca~V~2.1, β~1~             57.3 ± 4.3    ND             77.1 ± 7.1    340 ± 55      13.7 ± 2.9   43.9 ± 7.3    8
  Ca~V~2.1 GGG, β~1~         98.0 ± 5.1    ND             63.3 ± 2.3    10.1 ± 1.2    36.9 ± 4.1   94.1 ± 10.2   7
  netCDI                                                                                                         
  Ca~V~1.2, β~2a~            69.5 ± 2.6    ND             51.1 ± 2.7    20.3 ± 4.2    19.6 ± 2.7   96.8 ± 25.6   9
  Ca~V~1.2 AAA, β~2a~        72.3 ± 3.4    ND             53.3 ± 5.1    17.8 ± 1.3    20.4 ± 2.9   98.7 ± 25.9   5
  Ca~V~1.2 6A, β~2a~         60.5 ± 3.3    ND             40.4 ± 4.0    24.8 ± 1.0    21.8 ± 1.7   118 ± 13      5
  Ca~V~1.2, β~1~             75.3 ± 1.7    ND             57.0 ± 2.1    27.0 ± 1.8    23.1 ± 2.4   177 ± 32      5
  Ca~V~1.2, β~2b~            72.9 ± 1.7    ND             55.9 ± 3.2    25.4 ± 1.3    20.9 ± 1.0   165 ± 22      5
  Ca~V~1.2                   36.6 ± 1.3    ND             34.2 ± 4.2    216 ± 55      12.1 ± 2.0   40.7 ± 13.0   6
  Ca~V~1.2 HotA, β~2a~       35.6 ± 4.2    ND             33.0 ± 4.3    239 ± 42      12.6 ± 1.9   45.3 ± 9.9    5
  Ca~V~1.2 GGG, β~2a~        43.7 ± 3.6    ND             37.2 ± 2.1    217 ± 16      16.9 ± 4.1   40.9 ± 5.4    8
  Ca~V~1.2 GGG/HotA, β~2a~   15.6 ± 6.2    ND             20.7 ± 6.1    258 ± 86      ---          ---           7
  Ca~V~1.2 6G, β~2a~         19.8 ± 5.4    ND             25.4 ± 8.9    214 ± 54      ---          ---           8
  Ca~V~1.2 GGG, β~1~         41.9 ± 3.8    ND             57.9 ± 3.9    350 ± 31      9.5 ± 4.1    56.2 ± 8.6    5
  Ca~V~1.2 GGG, β~2b~        42.2 ± 4.3    ND             50.4 ± 10.3   356 ± 92      18.4 ± 2.0   54.7 ± 10.5   4

Data are expressed as mean values ± SD. τ values were determined at a holding potential of +20 mV (see Materials and methods). t~i300~ and t~i2400~ denote percent inactivation at 300 and 2,400 ms, respectively. ND, a value not determined.

Ca~V~1.2 GGG expressed without Ca~V~β~2a~ shows VDI that is 1.8-fold faster than Ca~V~1.2 expressed without Ca~V~β~2a~ ([Table I](#tbl1){ref-type="table"} and Fig. S1), a difference that could indicate that the GGG mutation is able to affect the Ca~V~α~1~ subunit VDI response in the absence of Ca~V~β modulation. *Xenopus* oocytes are known to express Ca~V~β~3~ ([@bib76]), a subunit that accelerates VDI and whose presence could confound interpretation of experiments in which Ca~V~α~1~ subunits are expressed in the absence of Ca~V~β coinjection. To get a cleaner assessment regarding whether the GGG mutation affects Ca~V~α~1~ subunit VDI properties, we examined the effect of the GGG mutant in the context of Ca~V~α~1~ subunits that bear a triple mutant in the Ca~V~β high affinity binding site, denoted as HotA, which renders the channels incapable of binding Ca~V~β ([@bib80]). The inactivation properties Ca~V~1.2 HotA and Ca~V~1.2 GGG/HotA (Fig. S1) are indistinguishable (τ = 601 ± 211 ms and 607 ± 277 ms, respectively; P = 0.99). Further, the VDI τ values are similar to Ca~V~1.2 alone. (τ~1~ = 455 ± 99 ms) ([Fig. 1, B and C](#fig1){ref-type="fig"}, and [Table I](#tbl1){ref-type="table"}). These results indicate that the VDI properties of the Ca~V~1.2 α~1~ subunit in the absence of Ca~V~β modulation are unaffected by the GGG mutation. The VDI τ values and extent of inactivation for the HotA channels were not significantly different from GGG and 6G channels coexpressed with Ca~V~β~2a~ ([Table I](#tbl1){ref-type="table"}) (one-way ANOVA for VDI τ values, P = 0.45; t~i300~, P = 0.28). Thus, the effects of the glycine mutants on VDI appear to arise from the loss of the influence of Ca~V~β~2a~ modulation and indicate that the intact IS6-AID linker is required for functional modulation of VDI by Ca~V~β~2a~.

In addition to the faster τ values and increased extent of inactivation, Ca~V~1.2 GGG channels lacked the characteristic hyperpolarizing shift in the G-V relationship caused by Ca~V~β~2a~ coexpression ([@bib56]; [@bib51]; [@bib83]) ([Fig. 1 D](#fig1){ref-type="fig"}, Figs. S2 and S3 A, and [Table II](#tbl2){ref-type="table"}) and were not significantly different from channels expressed in the absence of Ca~V~β~2a~ or from Ca~V~1.2 HotA. In contrast, AAA channels had biophysical properties that were indistinguishable from wild-type Ca~V~1.2 ([Fig. 1 D](#fig1){ref-type="fig"}, Fig. S3 A, and [Table II](#tbl2){ref-type="table"}).

###### 

Ca~V~1.2 and Mutant Ca~V~1.2 G-V Relationships

                         Ba^2+^        Ca^2+^                    
  ---------------------- ------------- ----------- ------------- ------------
  Construct              V~0.5~ (mV)   K~a~        V~0.5~ (mV)   K~a~
  Ca~V~1.2, β~2a~        −2.1 ± 3.1    7.0 ± 0.5   7.8 ± 2.6     9.2 ± 0.8
  Ca~V~1.2 AAA, β~2a~    −0.7 ± 4.4    6.7 ± 1.2   7.6 ± 2.9     8.7 ± 0.8
  Ca~V~1.2               11.2 ± 3.2    8.2 ± 1.0   21.0 ± 1.7    10.1 ± 0.5
  Ca~V~1.2 HotA, β~2a~   9.6 ± 4.3     8.1 ± 1.4   20.9 ± 1.4    10.2 ± 0.4
  Ca~V~1.2 GGG, β~2a~    8.2 ± 2.5     8.0 ± 0.8   16.8 ± 3.2    9.9 ± 0.7
  Ca~V~1.2 6G, β~2a~     4.7 ± 2.4     7.7 ± 0.9   18.4 ± 2.0    9.7 ± 0.9
  Ca~V~1.2 GGG           8.8 ± 3.9     8.8 ± 1.0   16.5 ± 3.4    10.7 ± 0.8

V~0.5~ and slope factor values for Ca~V~1.2 and mutants in barium and calcium. Data were fit using the equation I = G~max~ \* (V~m~ − V~rev~)/(1 + exp (V~0.5~ − V~m~)/K~a~), where I is the measured peak current at each V~m~, G~max~ is the maximal conductance, V~m~ is the test potential, V~rev~ is the reversal potential, V~0.5~ is the midpoint of activation, and K~a~ is the slope factor ([@bib41]). n-values are identical to the values for equivalent constructs in [Table I](#tbl1){ref-type="table"}.

Even though the GGG mutant does not affect any residues that are important for the AID-Ca~V~β high affinity interaction ([@bib80]), it was important to test whether the loss of modulation in the GGG background arose from an unexpected effect on Ca~V~β~2a~ association with the pore-forming subunit. Ca~V~β~2a~ coexpression potently stimulates the total macroscopic current on wild-type Ca~V~1.2 channels ([@bib56]; [@bib51]), an effect that was retained for Ca~V~β~2a~ coexpression with Ca~V~1.2 GGG (Fig. S4). Thus, the changes in both VDI and G-V modulation resulting from glycine mutations in the IS6-AID linker must arise from a loss of functional coupling and not from a loss of the physical interaction between Ca~V~β~2a~ and the Ca~V~α~1~ subunit.

To test if the importance of the IS6-AID linker for VDI generalized to other high voltage--activated Ca~V~s, we made the analogous substitutions in the IS6-AID linker of a Ca~V~2 α~1~-subunit, Ca~V~2.1 ([Fig. 1 A](#fig1){ref-type="fig"}). Similar to the effects of the triple-glycine substitution in Ca~V~1.2, coexpression of Ca~V~2.1 GGG with Ca~V~β~2a~ results in channels having greatly increased VDI compared with wild type ([Fig. 1 E](#fig1){ref-type="fig"} and [Table I](#tbl1){ref-type="table"}). The Ca~V~2.1 GGG mutation caused a new fast inactivation component (τ~2~ = 17.8 ± 2.2 ms), increased the extent of the main inactivation component by approximately sixfold relative to wild type (A~1~ = 10.0 ± 1.3% vs. A~1~ = 59.3 ± 8.6%, respectively), and brought about an approximately sixfold increase in t~i300~ (36.9 ± 4.1% vs. 6.5 ± 1.3%, respectively), a comparable effect relative to that observed in Ca~V~1.2 GGG. Substitution of six glycines, denoted as Ca~V~2.1 6G, gave rise to channels with VDI properties similar to Ca~V~2.1 GGG, indicating that as in the Ca~V~1.2 case, an IS6-AID linker triple-glycine substitution is sufficient for uncoupling the VDI modulatory effects of Ca~V~β~2a~ from the pore-forming subunit. Alanine substitution at the same positions, Ca~V~2.1 AAA and Ca~V~2.1 6A, only had marginal effects on VDI, suggesting that none of the side chains deleted by the multiple glycine substitutions was responsible for the VDI acceleration. Collectively, the data indicate that an intact IS6-AID linker helix is essential for Ca~V~β~2a~-dependent modulation of Ca~V~1 and Ca~V~2 VDI.

Glycine Substitutions Disrupt the Ability of the IS6-AID Linker to Form an α-Helix
----------------------------------------------------------------------------------

To determine the structural consequences of our substitutions in the IS6-AID linker, we examined the secondary structure content of peptides corresponding to Ca~V~1.2 wild-type, AAA, and GGG IS6-AID linkers ([Fig. 2 A](#fig2){ref-type="fig"}). Under aqueous conditions, CD experiments indicated that the helical contents of all three versions of the IS6-AID linker are low, \<10% ([Fig. 2 A](#fig2){ref-type="fig"}). To reveal whether the substitutions affect the ability of the IS6-AID linker to adopt a helical structure as intended, we measured the effects on the peptide CD spectra caused by the addition of TFE, a solvent that induces helical structure in a manner that reflects polypeptide intrinsic helicogenic properties ([@bib66]; [@bib10]). The CD spectra reveal a gradual acquisition of helical content concomitant with an increase in TFE concentration ([Fig. 2 A](#fig2){ref-type="fig"}). Under conditions of maximal TFE concentration (50% TFE), both wild-type and AAA peptides displayed the hallmark double minima associated with α-helical structure ([@bib7]) and helical contents of 72 and 64%, respectively ([Fig. 2 B](#fig2){ref-type="fig"}). The slightly diminished amount of helical character in AAA IS6-AID peptide relative to wild type may originate in the loss of the potential stabilizing (i, i+4) ionic interaction ([@bib50]) that could form between lysine 416 and aspartate 420. In contrast, GGG IS6-AID peptide has only 28% helical content under conditions in which the other peptides have reached their maximal helix content ([Fig. 2, A and B](#fig2){ref-type="fig"}). These data provide strong support for the idea that the GGG substitution is sufficient to break the helical character of the IS6-AID linker, are in agreement with the effects seen in the CD spectra of similar peptides from Ca~V~.2.2 ([@bib2]), and strongly suggest that the functional uncoupling we observe between Ca~V~β~2a~ and Ca~V~1.2 results from disruption of helical structure in the IS6-AID linker.

![Glycine substitution in IS6-AID linker disrupts helical structure. (A) Mean residue ellipticity at 222 nm for IS6-AID linker peptide, and AAA and GGG mutant peptides as a function of TFE concentration. Peptide sequence is shown. Black highlights the site of the GGG and AAA mutations. (B) IS6-AID linker peptide CD spectra at a peptide concentration of 50 µM in 50% TFE.](JGP_200810143_RGB_Fig2){#fig2}

Rank Order Effects of Ca~V~β Isoforms Remain in the Presence of Disrupted IS6-AID Linker
----------------------------------------------------------------------------------------

Prior studies of VDI rates imparted to Ca~V~α~1~ subunits by various Ca~V~β isoforms demonstrated a stereotyped rank order: fastest to slowest, Ca~V~β~1~ \> Ca~V~β~2b~ \> Ca~V~β~2a~ ([@bib53]; [@bib71]; [@bib20]; [@bib84]). Coexpression of Ca~V~1.2 with Ca~V~β~1~, Ca~V~β~2b~, or Ca~V~β~2a~ results in VDI that is 3.2- and 1.3-fold faster for Ca~V~β~1~ and Ca~V~β~2b~ relative to Ca~V~β~2a~ ([Fig. 3 A](#fig3){ref-type="fig"} and [Table I](#tbl1){ref-type="table"}). Additionally, the mutant subunit ssCa~V~β~2a~ ([@bib15]), which lacks the N-terminal palmitoylation that causes Ca~V~β~2a~ to retard VDI ([@bib16]; [@bib58]; [@bib61]), displays VDI that is 1.8-fold faster than Ca~V~β~2a~ and similar to Ca~V~β~2b~.

![Ca~V~β isoform rank order VDI effects remain in the presence of disrupted IS6-AID linker. Representative normalized I~Ba~ traces for the indicated Ca~V~β subunits coexpressed with (A) Ca~V~1.2 and (B) Ca~V~1.2 GGG. Note the different timescales. (C) Representative normalized I~Ba~ traces for coexpression of Ca~V~β~1~ and Ca~V~β~2a~ with Ca~V~2.1 and Ca~V~2.1 GGG.](JGP_200810143_RGB_Fig3){#fig3}

Having established that different Ca~V~β subunits impart stereotyped VDI differences to Ca~V~1.2, and that GGG causes a clear acceleration of Ca~V~1.2 VDI in the presence of Ca~V~β~2a~ ([Fig. 1 B](#fig1){ref-type="fig"}), we investigated how the GGG mutation affected the VDI modulation of Ca~V~1.2 by the different Ca~V~β isoforms. Ca~V~1.2 GGG channels coexpressed with Ca~V~β~1~, Ca~V~β~2b~, or ssCa~V~β~2a~ all have greatly accelerated VDI compared with wild-type Ca~V~1.2 coexpressed with the same isoforms (VDI τ value increases of 5.6-, 10.7-, and 7.8-fold for Ca~V~β~1~, Ca~V~β~2b~, and ssCa~V~β~2a~, respectively) ([Fig. 3, A and B](#fig3){ref-type="fig"}, and [Table I](#tbl1){ref-type="table"}). Interestingly, the rank order VDI effects relative to Ca~V~β~2a~ are retained (2.4-, 1.8-, and 1.9-fold faster for Ca~V~β~1~, Ca~V~β~2b~, and ssCa~V~β~2a~ relative to Ca~V~β~2a~). Similar experiments using wild-type Ca~V~2.1, Ca~V~2.1 GGG, Ca~V~β~1~, and Ca~V~β~2a~ show that the GGG substitution causes Ca~V~2.1 channels to inactivate considerably faster regardless of the Ca~V~β isoform while also maintaining the isoform-specific rank order ([Fig. 3 C](#fig3){ref-type="fig"}). The retention of the relative VDI rank order in the context of disrupted Ca~V~1 and Ca~V~2 IS6-AID linkers suggests the existence of conserved secondary interaction sites between Ca~V~β and yet to be defined regions of the pore-forming subunits. The observation that Ca~V~1.2 GGG and Ca~V~2.1 GGG channels both inactivate faster than wild type regardless of the Ca~V~β isoform provides further support for the idea that the IS6-AID linker forms a rigid connection that couples Ca~V~β to the pore. Thus, the importance of the integrity of the IS6-AID linker for Ca~V~β modulation of VDI is a common element of high voltage--activated Ca~V~α~1~ architecture.

Disruption of IS6-AID Linker or Ca~V~β Binding Reduces CDI
----------------------------------------------------------

Given the clear effects of IS6-AID linker disruption on VDI, we investigated whether disruption of the IS6-AID linker affected the other prominent mode of Ca~V~ inactivation, CDI. When calcium ions are used as the charge carriers, the time-dependent decay of Ca~V~ currents arises from two processes: CDI and VDI, which is calcium independent. As long as CDI is much faster than VDI, apparent changes in inactivation of Ca~V~ calcium currents caused by the presence of different subunits or resulting from mutations should reflect alteration of the actual extent of inactivation driven by calcium-dependent feedback modulation. However, when CDI and VDI occur on similar timescales, the observed inactivation represents contributions from both processes and can confound the analysis. Measurement of the ratio of I~Ca~ and I~Ba~ from the same cell permits one to separate CDI and VDI contributions. Division of normalized I~Ca~, which measures inactivation by CDI and VDI, by normalized I~Ba~, which reflects the fraction of channels available to undergo inactivation, yields a ratio that isolates the contribution of calcium-dependent processes to the overall observed inactivation ([@bib4]). The more common practice of taking the simple difference between CDI and VDI can underestimate effects on CDI when VDI is accelerated, a problem that the normalized I~Ca~/I~Ba~ metric avoids. Because many of our manipulations accelerate VDI, we used the normalized I~Ca~/I~Ba~ metric, which we denote as netCDI, to analyze the inactivation properties of the mutant channels.

A previous study of wild-type Ca~V~1.2 channels expressed in a mammalian cell line suggested that in some cases, I~Ba~ may also undergo current-dependent inactivation ([@bib27]), a condition that if present to a substantial degree would complicate the netCDI analysis. To test whether such a phenomenon occurred in our *Xenopus* oocyte experimental setup, we examined the inactivation properties of I~Ba~ using a double-pulse protocol ([Fig. 4 C](#fig4){ref-type="fig"}). Comparison of the I~Ba~ prepulse and test pulse amplitudes does not reveal a U-shaped dependence that would be a signature of VDI current-dependent inactivation ([Fig. 4 C](#fig4){ref-type="fig"}) and supports the use of netCDI as a means for parsing inactivation into effects from CDI and VDI.

![IS6-AID linker disruption reduces CDI. (A) Representative netCDI (I~Ca~/I~Ba~) at a test potential of +20 mV for the combinations of the indicated Ca~V~1.2 subunits and Ca~V~β~2a~. (B) t~i300~ values from A. Results of unpaired *t* tests are indicated as follows: N.S., P \> 0.05, not significant; \*\*\*, P \< 0.001. (C) Isochronal inactivation of Ca~V~1.2 (*n* = 4, black X's, netCDI; *n* = 4, black open squares, VDI), Ca~V~1.2 GGG netCDI (*n* = 4, gray), and Ca~V~1.2 GGG/HotA netCDI (*n* = 5, orange). Inactivation extent comparing the ratio of prepulse and test pulse current amplitudes plotted as a function of the test voltage. The pulse protocol is shown at the top. (D) G-V relationships in calcium for the indicated combinations of Ca~V~1.2 subunits and Ca~V~β~2a~.](JGP_200810143_RGB_Fig4){#fig4}

In striking contrast to the VDI acceleration caused by the IS6-AID linker GGG mutation, two-electrode voltage clamp experiments in *Xenopus* oocytes in which calcium ions were used as the charge carrier showed that the GGG mutation unexpectedly decreased netCDI ([Fig. 4 A](#fig4){ref-type="fig"} and [Table I](#tbl1){ref-type="table"}). The triple-glycine mutation caused drastic reductions relative to wild type in both the main inactivating component (τ~1~ = 217 ± 16 ms vs. 20.3 ± 4.2 ms, respectively) and extent of inactivation, t~i300~ (43.7 ± 3.6% vs. 69.5 ± 2.6%) ([Fig. 4, A and B](#fig4){ref-type="fig"}, and [Table I](#tbl1){ref-type="table"}). Unlike the VDI case in which GGG and 6G substitutions had equivalent effects on inactivation, Ca~V~1.2 6G showed a further reduction in netCDI extent (t~i300~ =19.8 ± 5.4%), although the time constant of the main inactivating component was not changed. A similarly strong reduction of netCDI extent was seen in the GGG/HotA mutant ([Fig. 4 A](#fig4){ref-type="fig"}). In contrast to the potent changes elicited by the glycine substitutions, Ca~V~1.2 AAA and Ca~V~1.2 6A netCDI were very similar to wild type ([Fig. 4 A](#fig4){ref-type="fig"} and [Table I](#tbl1){ref-type="table"}). The Ca~V~1.2 6G and Ca~V~1.2 GGG/HotA mutants expressed at lower levels than most other mutant channels (Table S2). To test the possibility that the additional reduction in netCDI observed in these cases was due to an indirect effect caused by the low current amplitudes, we recorded wild-type Ca~V~1.2 currents at comparable expression levels (Fig. S5). Comparison of these currents showed no change in netCDI. Thus, the changes in netCDI can be confidently attributed to direct effects on the channel that arise from the mutations and not from differences in current amplitudes.

To examine the changes to netCDI over a broad voltage range, we measured netCDI using a multi-pulse protocol in which the extent of inactivation was measured following a variable voltage pulse and compared with a control prepulse ([Fig. 4 C](#fig4){ref-type="fig"}). Under this protocol, wild-type Ca~V~1.2 netCDI displays the typical inverted U-shape dependence expected of a calcium-dependent modulatory process. This dependence is markedly reduced for both Ca~V~1.2 GGG and Ca~V~1.2 GGG/HotA ([Fig. 4 C](#fig4){ref-type="fig"}). The drastic reduction in the U-shape dependence of inactivation in the mutant channels adds further support for the idea that the IS6-AID linker and Ca~V~β have a role in CDI.

Comparison of netCDI measured from Ca~V~1.2 coexpressed with Ca~V~β~2a~, Ca~V~1.2 expressed without Ca~V~β, and Ca~V~1.2 HotA, which cannot bind Ca~V~β, revealed an unexpected effect of Ca~V~β~2a~. Ca~V~β~2a~ causes a dramatic, ∼10-fold increase in netCDI (τ~1~ = 20.3 ± 4.2 ms, 216 ± 55 ms, and 239 ± 42 ms, respectively) ([Fig. 4 A](#fig4){ref-type="fig"} and [Table I](#tbl1){ref-type="table"}). This netCDI acceleration stands in stark disparity to the approximately eightfold retardation Ca~V~β~2a~ imparts to VDI relative to channels lacking Ca~V~β. Hence, Ca~V~β~2a~ has the opposite functional effects on CDI and VDI. This paradoxical effect has not been noted previously. netCDI for Ca~V~1.2 GGG channels coexpressed with Ca~V~β~2a~ is indistinguishable from Ca~V~1.2 channels expressed in the absence of a Ca~V~β subunit and HotA channels that cannot bind Ca~V~β (τ~1~ = 217 ± 16 ms, 216 ± 55 ms, and, 239 ± 42 ms, respectively). Thus, even though the GGG mutation has opposite effects on Ca~V~β~2a~-mediated VDI and CDI, accelerating the former while decelerating the latter, the net effect is the same. The Ca~V~1.2 GGG channels inactivate with τ values equivalent to channels lacking Ca~V~β~2a~ modulation.

Similar to the effect seen using barium as a charge carrier, the use of calcium as the charge carrier reveals that Ca~V~1.2 GGG lacks the hyperpolarizing shift in the G-V relationship caused by Ca~V~β~2a~ ([Fig. 4 D](#fig4){ref-type="fig"}, Fig. S3 B, and [Table II](#tbl2){ref-type="table"}). Further, the Ca~V~1.2 GGG/Ca~V~β~2a~ channels show similar G-V relationships to wild-type Ca~V~1.2 expressed in the absence of Ca~V~β and to Ca~V~1.2 HotA. In contrast, Ca~V~1.2 AAA coexpressed with Ca~V~β~2a~ behaves like wild-type Ca~V~1.2 ([Fig. 4 D](#fig4){ref-type="fig"}). Therefore, disruption of the IS6-AID linker shows similar abrogation of effects on voltage activation caused by Ca~V~β~2a~, regardless of the divalent charge carrier.

Together with the data from the studies of IS6-AID linker peptides, the results strongly suggest that the observed reduction in netCDI for Ca~V~1.2 GGG and Ca~V~1.2 6G is the consequence of the disruption of the IS6-AID linker. These data provide compelling evidence that both Ca~V~β and an intact IS6-AID linker are required for netCDI and suggest that there is an intimate dependence between elements that drive CDI, namely the Ca^2+^--CaM-IQ domain complex ([@bib34]), and components that control VDI.

Ca~V~β Isoform Identity Has Little Influence on Ca~V~1.2 netCDI
---------------------------------------------------------------

In light of the clear rank order effects that different Ca~V~β isoforms have on VDI, we asked whether there were similar differences in netCDI when different Ca~V~βs were present. Wild-type Ca~V~1.2 channels coexpressed with Ca~V~β~1~, Ca~V~β~2a~, or Ca~V~β~2b~ show small differences in CDI but no real difference when netCDI is considered (τ values of 20--30 ms) ([Fig. 5 A](#fig5){ref-type="fig"} and [Table I](#tbl1){ref-type="table"}). Incorporation of the triple-glycine mutant in the Ca~V~1.2 IS6-AID linker causes a reduction in CDI in the presence of Ca~V~β~1~, Ca~V~β~2b~, and Ca~V~β~2a~ (τ~1~ = 200--350 ms; [Table I](#tbl1){ref-type="table"}). Even though there appear to be differences between the Ca~V~β isoforms with respect to inactivation in calcium ([Fig. 5 B](#fig5){ref-type="fig"}, middle, and Table S1), these distinctions are due almost exclusively to the underlying VDI differences ([Fig. 5 B](#fig5){ref-type="fig"}, left) and vanish when one considers netCDI ([Fig. 5 B](#fig5){ref-type="fig"}, right, and [Table I](#tbl1){ref-type="table"}). Together with the HotA CDI results, these data suggest that although a Ca~V~β subunit is required for CDI, all Ca~V~β isoforms support netCDI equally. Thus, the primary route for coupling CDI components to the pore would appear to be through the IS6-AID linker and not through secondary interactions sites that contribute to isoform-specific VDI modulation differences.

![Effects of Ca~V~β isoforms on calcium inactivation stem from underlying effects on VDI. Normalized inactivation curves measured at +20 mV for (A) Ca~V~1.2 and (B) Ca~V~1.2 GGG subunits coexpressed with Ca~V~β~1~, Ca~V~β~2a~, Ca~V~β~2b~, or in the absence of Ca~V~β. (Left) VDI is shown and is reproduced for comparison from the first 300 ms of [Fig. 3 (A and B)](#fig3){ref-type="fig"}. (Middle) Inactivation in calcium. (Right) netCDI.](JGP_200810143_RGB_Fig5){#fig5}

CDF Is Reduced by Disruption of Either IS6-AID Linker or Ca~V~β Association
---------------------------------------------------------------------------

Ca~V~1.2 channels display a phenomenon known as CDF, which is unmasked in the context of a point mutation, I1624A, in the C-terminal tail IQ domain that comprises the primary Ca^2+^/CaM binding site ([@bib89], [@bib90]; [@bib39]; [@bib78]). Given the pronounced effects of the IS6-AID linker GGG mutation and the importance of Ca~V~β for both VDI and CDI, we tested whether CDF might also rely upon an intact IS6-AID linker or the Ca~V~β subunit. Under conditions of similar current amplitude, the GGG mutation causes a reduction in Ca~V~1.2 I1624A CDF of almost two thirds (13.8 ± 8.2% GGG/I1624A vs. 38.9 ± 12.3% I1624A, respectively). In contrast, the corresponding AAA mutant did not alter CDF significantly (37.5 ± 12.1%). Ca~V~1.2 I1624A channels incapable of binding Ca~V~β through the incorporation of the HotA mutations show a complete absence of CDF ([Fig. 6](#fig6){ref-type="fig"}). This result agrees with the observation that Ca~V~β is central to the CDF mechanism ([@bib32]). Collectively, these data suggest that CDF requires both an intact IS6-AID linker and a Ca~V~β subunit, and that both Ca~V~1.2 netCDI and CDF use the same components, including the IS6-AID linker and Ca~V~β for communicating with the transmembrane pore.

![CDF is reduced by disruption of the IS6-AID linker and loss of Ca~V~β binding. (A) Relative current increase between the last (40th) and first +20-mV pulses at 3 Hz for Ca~V~1.2 and the indicated mutants. Parentheses indicate the number of oocytes tested. Results of unpaired *t* tests are indicated as follows: N.S., P \> 0.05, not significant; \*\*\*, P \< 0.001. (B) Exemplar current traces for Ca~V~1.2 I1624A, Ca~V~1.2 GGG/I1624A, and Ca~V~1.2 HotA/I1624A in a 3-Hz 40-pulse train normalized to the peak of the first pulse.](JGP_200810143_GS_Fig6){#fig6}

DISCUSSION
==========

The process of inactivation is critical for Ca~V~ function and forges important connections between electrical signaling, activity-dependent feedback modulation of the channel, and activation of other calcium-dependent signaling cascades. Although a definitive molecular mechanism has yet to emerge, several models have been forwarded for how the components that govern the two principal inactivation processes, VDI and CDI, communicate with the transmembrane pore to regulate inactivation. The models fall into two distinct classes: those that assert that VDI and CDI use the same physical components to regulate the open state of the transmembrane pore ([@bib12]; [@bib74]; [@bib68]; [@bib28]; [@bib43]), and those that maintain VDI and CDI use distinct physical components ([@bib45]; [@bib33]; [@bib4]).

Identification of elements that affect VDI is relatively straightforward. Examination of the consequences of mutational manipulations or changes in subunit composition for inactivation when barium is the permeant ion provides an unambiguous VDI metric. Consequently, characterization of mutations in various elements of the Ca~V~1.2 C terminus including the IQ domain, which has a prominent role in CDI ([@bib89]; [@bib4]), putative EF-hand, and sequences between IQ domain and EF-hand ([@bib91]; [@bib43]), have indicated that many components that are thought to be important for CDI also affect VDI.

On the contrary, delineation of the extent to which components that are thought to dominate VDI, such as the Ca~V~β/I-II loop complex ([@bib53]; [@bib71]; [@bib20]), contribute to inactivation under conditions when calcium is the permeant ion can be problematic. In the regime where VDI and CDI occur on the same timescale, perturbation to elements that contribute to VDI may also alter apparent CDI rates. Such changes might lead one to mistakenly conclude that VDI components have a role in CDI and that perhaps both inactivation processes use common elements. This point has been clearly articulated recently by [@bib4], who present a new and important means of analyzing Ca~V~ inactivation that allows for a dissection of the relative contributions of VDI and CDI to the overall inactivation process. The calculation of the normalized I~Ca~/normalized I~Ba~ ratio ([@bib4]), a parameter we call netCDI, allows the isolation of the inactivation component that is specifically conferred by calcium and avoids complications that could be caused by acceleration of VDI. This type of analysis indicates that prior evidence used to support the idea of a shared role for Ca~V~β action in VDI and CDI ([@bib12]) can be explained entirely by differences in how the different Ca~V~βs act on VDI ([@bib4]) (compare [Fig. 5 A](#fig5){ref-type="fig"}). Thus, whether CDI requires the VDI components or proceeds via an independent mechanism has remained an open question.

Structural Integrity of the IS6-AID Linker Is Essential for VDI and CDI
-----------------------------------------------------------------------

Our experiments testing the importance of the structural integrity of the IS6-AID linker support the idea that in Ca~V~1 and Ca~V~2 channels, the IS6-AID linker is a helix that functions as a rigid rod connecting Ca~V~β to the pore domain ([@bib54]; [@bib79]; [@bib2]) ([Fig. 7 A](#fig7){ref-type="fig"}). This structural connection appears to be responsible for a large fraction of the VDI modulation that any Ca~V~β isoform imparts on Ca~V~α~1~ subunits and for the effects Ca~V~β has on channel activation (compare [Figs. 1](#fig1){ref-type="fig"} and [4](#fig4){ref-type="fig"}).

![Cartoon model of a Ca~V~ channel. Based on the likely gross similarly between Ca~V~ and Kv transmembrane portions, the Kv1.2 transmembrane domains (gray surface; PDB accession no. [2A79](2A79)) are used to represent the Ca~V~ transmembrane domains. The IS6-AID linker (red) was modeled manually by building a helix of corresponding length between the Kv1.2 S6 helix C terminus (dark gray) and AID helix (light gray) from the Ca~V~β~2a~--AID complex (PDB accession no. [1T0J](1T0J)). The Ca~V~β~2a~--AID complex is shown as follows: green, SH3 domain; light blue, NK domain; light gray, AID. N-terminal Ca~V~β~2a~ variable segment, V1, of unknown structure, is shown anchored to the membrane via N-terminal palmitoylation, and the V2 loop is indicated. Arrow along the IS6-AID linker indicates communication between Ca~V~β and the pore domain. This is lost in the multiple glycine mutants (bottom) and affects VDI, CDI, and CDF. Curved arrow between the Ca^2+^/CaM-IQ domain complex (PDB accession no. [2BE6](2BE6)), Ca^2+^/CaM (dark blue), and IQ helix (gray) represents the functional interaction between the C-terminal tail complex and the Ca~V~β~2a~--AID complex required for CDI and CDF. In Ca~V~1.2 GGG (bottom), IS6-AID helix disruption blunts the influence of the Ca^2+^/CaM-IQ domain on the transmembrane pore.](JGP_200810143_RGB_Fig7){#fig7}

X-ray crystallographic ([@bib14]; [@bib54]; [@bib79]) and CD studies ([@bib54]; [@bib80]) indicate that the helical structure of the AID, which is integral to the Ca~V~α~1~--Ca~V~β interaction, is induced by formation of the AID--Ca~V~β complex. The presence of such a well-supported helix and consideration of the established importance of such a template for nucleating helix formation ([@bib88]; [@bib48]; [@bib82]; [@bib55]) suggest that the AID helix can promote the propagation of α-helical structure in the IS6-AID linker ([@bib54]; [@bib79]). In agreement with this hypothesis, we find that mutations that reduce the helical propensity of the IS6-AID linker and mutations that eliminate Ca~V~β binding to the AID have similar functional effects.

Remarkably, we find that disruption of the IS6-AID linker by the GGG mutation or the loss of Ca~V~β binding caused by the disruption of the AID-binding hotspot by the HotA mutations ([@bib80]) also causes large reductions (\>10-fold) in the main inactivation component of netCDI. The remaining netCDI can be essentially eliminated by the introduction of additional flexibility into the IS6-AID linker (Ca~V~1.2 6G) or by the GGG/HotA combination ([Fig. 4](#fig4){ref-type="fig"}). These data constitute strong evidence that CDI relies on Ca~V~β and portions of the I-II loop, physical components that have been traditionally associated with VDI.

Interestingly, the disruption of the IS6-AID linker structural integrity affects VDI and CDI in opposite directions; VDI is accelerated, while CDI is slowed down. By use of the netCDI analysis, we uncovered a previously unrecognized difference between how Ca~V~β~2a~ affects VDI and CDI. Ca~V~β~2a~, which slows VDI relative to channels lacking a Ca~V~β subunit ([@bib53]; [@bib71]) ([Fig. 1 B](#fig1){ref-type="fig"}), accelerates netCDI ([Fig. 4 A](#fig4){ref-type="fig"}). These changes mirror the seemingly opposite effects of the GGG mutation on VDI and CDI in the presence of Ca~V~β~2a~. Thus, the VDI and CDI results are both consistent with the same interpretation; a rigid IS6-AID linker is absolutely required to couple Ca~V~β with the pore and indicate that Ca~V~β has a centrally important role in CDI.

Our data support the hypothesis that VDI and CDI act through shared components ([@bib12]; [@bib74]; [@bib68]; [@bib28]; [@bib43]) rather than through independent elements ([@bib45]; [@bib33]; [@bib4]). The observation that VDI proceeds through a process that includes gating charge immobilization whereas CDI does not has given support to the idea that VDI and CDI are mediated by distinct effector mechanisms ([@bib4]) and would seem at odds with the interpretation that both VDI and CDI act through a common element, namely Ca~V~β and the IS6-AID linker. However, our discovery that Ca~V~β~2a~ has opposite effects on VDI and CDI may provide a way to reconcile this observation. It suggests that the underlying structural rearrangements that cause VDI and CDI are not equivalent, even though both rely upon the coupling of Ca~V~β to the pore via a rigid IS6-AID linker. Further support for this idea comes from the observations that the different Ca~V~β isoforms have dissimilar effects on VDI but not netCDI ([Fig. 5](#fig5){ref-type="fig"}), and that relative to the GGG mutation, GGG/HotA affects netCDI but not VDI ([Fig. 4](#fig4){ref-type="fig"} and [Table I](#tbl1){ref-type="table"}).

How Do VDI and CDI Elements Communicate?
----------------------------------------

The functional evidence that the main VDI and CDI elements operate in an interdependent manner raises the question about the exact underlying molecular interactions that drive VDI and CDI. The simplest hypothesis is that, at least in one functional state, there is a direct physical interaction between the two major components of VDI and CDI, the Ca~V~β/Ca~V~α~1~-I-II loop and Ca^2+^/CaM/Ca~V~α~1~--C-terminal tail complexes. Unfortunately, robust evidence for such a direct physical interaction remains elusive. Pulldown experiments by [@bib43] have suggested that there could be an interaction between the isolated I-II loop and the Ca~V~1.2 C terminus; however, those experiments were done in the absence of Ca~V~β, conditions under which the AID portion of the I-II loop is not folded ([@bib54]; [@bib80]). Therefore, whether the observed interaction reflects authentic binding between two natively folded components remains an open question. Using a similar assay, [@bib87] reported the binding of Ca~V~β to the Ca~V~1.2 C terminus; however, this interaction was preserved even when a mutant construct that destroys Ca~V~β structural integrity, the ΔBID mutant, was used. Thus, the observed Ca~V~β--Ca~V~1.2 C terminus interaction cannot reflect a functionally relevant interaction. Our attempts to establish robust complexes between biochemically well-behaved constructs that include Ca~V~β, the I-II loop, and the C-terminal complex having defined stoichiometries have thus far been unsuccessful.

Even though the functional data indicate a codependency between the Ca~V~β/I-II loop and the calcium-sensing elements of the channel, such a functional link does not demand a direct physical association of these components. Given the substantial amount of Ca~V~ mass in the cytoplasm, ∼150 kD ([@bib81]), and that the Ca~V~β/Ca~V~α~1~-I-II loop and Ca^2+^/CaM/Ca~V~α~1~--C-terminal tail complexes comprise only a portion of this mass, it seems likely that interactions between the Ca~V~β/Ca~V~α~1~-I-II loop and Ca^2+^/CaM/Ca~V~α~1~--C-terminal tail complexes involve other yet to be determined elements from the pore-forming subunit intracellular portions. One candidate is the N-terminal cytoplasmic domain ([@bib40]; [@bib22]; [@bib75]). Defining the exact arrangement of the channel intracellular components and the state dependence of interactions between the Ca~V~β/I-II loop and CaM/C-terminal complexes remains an important goal. Further, it will be essential to determine how rearrangements within the channel cytoplasmic domains affect changes in the pore that may also participate in channel inactivation ([@bib3]).

Effects of IS6-AID Linker Disruption on VDI and CDI Are Incompatible with a Hinged Lid Model
--------------------------------------------------------------------------------------------

The details of the macromolecular conformational changes that cause Ca~V~ inactivation remain unknown. To account for the importance of the I-II linker in determining inactivation rates of Ca~V~ channels and chimaeras ([@bib12]; [@bib72]), Ca~V~ inactivation has been suggested to occur via an inactivation particle or hinged lid analogous to voltage-gated sodium channels ([@bib31]; [@bib77]). The N-terminal portion of the AID helix has been suggested as a candidate for a Ca~V~ inactivation particle ([@bib18]) based on the influence that charged residues on the AID external face in the Ca~V~β--AID complex have on VDI kinetics ([@bib37]; [@bib8]; [@bib18]).

From the homology and deep evolutionary relationship between Ca~V~s and voltage-gated potassium channels ([@bib38]), it is very likely that Ca~V~ IS6 is a helical pore-lining segment similar to the homologous region of voltage-gated potassium channels ([@bib49]). Our data indicate that the IS6-AID linker forms a continuous helix that bridges the AID helix and IS6. To assess the impact of such a structural element on the probable location of the Ca~V~β--AID complex relative to the pore, we modeled a helical IS6-AID linker onto the structure of the Kv1.2 transmembrane domains ([@bib49]). The resulting continuous helix places the Ca~V~β--AID complex ∼40 Å distant from the pore ([Fig. 7](#fig7){ref-type="fig"}). This structural arrangement is incompatible with a mechanism in which the Ca~V~β--AID acts as an inactivation particle that approaches the pore. The glycine substitutions that we tested are situated midway between the pore and Ca~V~β--AID complex and should impart increased flexibility to the IS6-AID linker. If the Ca~V~β--AID complex acted like an inactivation particle that needed to approach the pore, these substitutions would be expected to show a minimal effect. In contrast, we see greatly increased inactivation τ values ([Figs. 1](#fig1){ref-type="fig"} and [3](#fig3){ref-type="fig"}). Further, the absence of effects on inactivation in the case where no Ca~V~β is bound (e.g., Ca~V~1.2 GGG-Ca~V~β~2a~ vs. Ca~V~1.2 GGG/HotA-Ca~V~β~2a~), and where the helix propensity of the IS6-AID linker is increased by multiple alanine substitutions, also conflicts with the idea that there is some sort of inactivation particle formed by the Ca~V~β--AID complex. Thus, it seems difficult to reconcile the functional effects of the IS6-AID linker mutations with the I-II linker acting as a hinged lid or inactivation particle. Rather, our results support the idea that inactivation involves some type of constriction of the pore involving the S6 segments from each domain ([@bib86]; [@bib72]; [@bib13]).

A Second Interaction Site between Ca~V~β and Ca~V~α~1~ Is Important for VDI
---------------------------------------------------------------------------

The functional consequences of disrupting the helicity of the IS6-AID linker suggest that Ca~V~βs modulate VDI through two different routes. The principal mechanism appears to be through the IS6-AID linker as the changes in τ values caused by the GGG substitution are of the same magnitude as that caused by the absence of a Ca~V~β subunit ([Table I](#tbl1){ref-type="table"}). The fact that the rank order VDI effects of different Ca~V~β isoforms persists in the context of a disabled IS6-AID linker ([Fig. 3](#fig3){ref-type="fig"}) indicates that the IS6-AID linker is not the sole element involved. The palmitoylation of the N-terminal variable domain of Ca~V~β~2a~ remains an important factor that sets Ca~V~β~2a~ apart from the other Ca~V~βs. Additionally, there must be other functionally important sites of interaction between Ca~V~β and other portions of the pore-forming subunit that account for the remnant differences observed among the Ca~V~βs. One candidate for such interactions is the Ca~V~β V2 (or HOOK) domain, which connects the highly conserved SH3 and NK domains ([@bib35]; [@bib14]; [@bib54]; [@bib79]). Indeed, functional experiments support an important role for the V2 region in VDI. Chimeras that swap the V2 region between the core domains of Ca~V~β~1~ and Ca~V~β~2a~ result in an exchange of VDI properties ([@bib36]), and deletion of the Ca~V~β~2a~ V2 domain causes acceleration of VDI ([@bib63]). Our experiments show that ssCa~V~β~2a~ and Ca~V~β~2b~ do not have identical effects on VDI (e.g., 1.4-fold difference in τ; [Table I](#tbl1){ref-type="table"}), even though both share identical V2 domains. Thus, other Ca~V~β variable regions must also play a role in VDI. These two isoforms have multiple differences in the V1 and V3 that must bear the elements that contribute to the differing effects on VDI. In contrast, Ca~V~β subunit isoform identity has little effect on CDI ([Fig. 5](#fig5){ref-type="fig"}), suggesting that interactions between the Ca~V~β-variable regions and pore-forming subunit are not critical for CDI. Although the importance of the variable regions with respect to isoform-specific modulation of VDI seems clear from the perspective of the Ca~V~β subunit, the target sites on the pore-forming subunit remain unknown. Definition of the functionally relevant Ca~V~β subunit points of contact on the pore-forming subunit remains an important unresolved issue.

CDF and CDI Share Requirement for Ca~V~β and Intact IS6-AID Linker
------------------------------------------------------------------

Although the detailed mechanism for Ca~V~1.2 CDF remains unresolved ([@bib62]), three different macromolecular components appear to contribute: the complex of Ca^2+^/CaM and the Ca~V~α~1~ C-terminal tail IQ domain ([@bib89]; [@bib78]), Ca^2+^/CaM-dependent kinase II ([@bib1]; [@bib85]; [@bib39]; [@bib32]; [@bib46]), and Ca~V~β ([@bib32]). Our data support the critical role of Ca~V~β in CDF. Incorporation of the HotA mutations that prevent Ca~V~β binding ([@bib80]) eliminates the CDF that is unmasked by the I1624A IQ domain mutation ([Fig. 6](#fig6){ref-type="fig"}). Furthermore, we uncover a requirement for the IS6-AID linker. Disruption of the IS6-AID linker structure blunts CDF and provides new evidence that an intact rigid connection between the channel pore and Ca~V~β is also essential for CDF ([Fig. 6](#fig6){ref-type="fig"}). Collectively, our data show clearly that CDF and CDI share the same requirements, the presence of a Ca~V~β subunit and an intact IS6-AID linker, suggesting that these two processes use the same determinants to communicate with the pore.

Calcium influx into excitable cells is tightly regulated by a plethora of different processes. Our data strongly suggest that rearrangements of the intracellular Ca~V~ domains have effects on inactivation that are mediated by Ca~V~β through a rigid connection to the IS6 pore helix. Presently, very little is known about how Ca~V~ intracellular domains interact with each other in open-, closed-, or inactivated-channel states. Development of a true molecular description of Ca~V~ inactivation will require the definition of the physical intermolecular interactions present in each stage of the channel and how they rearrange. The definition of the central role of the Ca~V~β subunit for VDI, CDI, and CDF should focus attention on defining how this centrally important channel element interacts with other intracellular domains to modulate activity-dependent feedback modulation of the channel.
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